180 related articles for article (PubMed ID: 33842463)
1. 3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase
Fu X; Zhao R; Yoon G; Shim JH; Choi BY; Yin F; Xu B; Laster KV; Liu K; Dong Z; Lee MH
Front Cell Dev Biol; 2021; 9():638174. PubMed ID: 33842463
[TBL] [Abstract][Full Text] [Related]
2. Cell growth inhibition by 3-deoxysappanchalcone is mediated by directly targeting the TOPK signaling pathway in colon cancer.
Zhao R; Huang H; Choi BY; Liu X; Zhang M; Zhou S; Song M; Yin F; Chen H; Shim JH; Bode AM; Dong Z; Lee MH
Phytomedicine; 2019 Aug; 61():152813. PubMed ID: 31035049
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.
Roh E; Han Y; Reddy K; Zykova TA; Lee MH; Yao K; Bai R; Curiel-Lewandrowski C; Dong Z
Oncogene; 2020 May; 39(21):4170-4182. PubMed ID: 32277233
[TBL] [Abstract][Full Text] [Related]
4. Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.
Zhao R; Choi BY; Wei L; Fredimoses M; Yin F; Fu X; Chen H; Liu K; Kundu JK; Dong Z; Lee MH
Br J Pharmacol; 2020 May; 177(10):2303-2319. PubMed ID: 31985814
[TBL] [Abstract][Full Text] [Related]
5. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
[TBL] [Abstract][Full Text] [Related]
6. Cefradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of T-LAK cell-originated protein kinase.
Fan X; Duan Q; Ke C; Zhang G; Xiao J; Wu D; Zeng X; Chen J; Guo J; Zhou J; Shi F; Zhu F
Oncotarget; 2016 Apr; 7(17):24633-45. PubMed ID: 27016423
[TBL] [Abstract][Full Text] [Related]
7. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
Kim DJ; Li Y; Reddy K; Lee MH; Kim MO; Cho YY; Lee SY; Kim JE; Bode AM; Dong Z
Cancer Res; 2012 Jun; 72(12):3060-8. PubMed ID: 22523035
[TBL] [Abstract][Full Text] [Related]
8. Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase.
Xue P; Wang Y; Zeng F; Xiu R; Chen J; Guo J; Yuan P; Liu L; Xiao J; Lu H; Wu D; Pan H; Lu M; Zhu F; Shi F; Duan Q
Oncotarget; 2017 Apr; 8(16):27093-27104. PubMed ID: 28404919
[TBL] [Abstract][Full Text] [Related]
9. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells.
Abe Y; Matsumoto S; Kito K; Ueda N
J Biol Chem; 2000 Jul; 275(28):21525-31. PubMed ID: 10781613
[TBL] [Abstract][Full Text] [Related]
10. Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase.
Zhao S; Cui J; Cao L; Han K; Ma X; Chen H; Yin S; Zhao C; Ma C; Hu H
Phytother Res; 2023 Jul; 37(7):3057-3068. PubMed ID: 36882184
[TBL] [Abstract][Full Text] [Related]
11. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
Oh SM; Zhu F; Cho YY; Lee KW; Kang BS; Kim HG; Zykova T; Bode AM; Dong Z
Cancer Res; 2007 Jun; 67(11):5186-94. PubMed ID: 17545598
[TBL] [Abstract][Full Text] [Related]
12. T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer.
Ikeda Y; Park JH; Miyamoto T; Takamatsu N; Kato T; Iwasa A; Okabe S; Imai Y; Fujiwara K; Nakamura Y; Hasegawa K
Clin Cancer Res; 2016 Dec; 22(24):6110-6117. PubMed ID: 27334838
[TBL] [Abstract][Full Text] [Related]
13. Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway.
Cui J; Guo R; Wang Y; Song Y; Song X; Li H; Song X; Li J
Bioengineered; 2022 Feb; 13(2):4428-4440. PubMed ID: 35139768
[TBL] [Abstract][Full Text] [Related]
14. Targeting PRPK and TOPK for skin cancer prevention and therapy.
Roh E; Lee MH; Zykova TA; Zhu F; Nadas J; Kim HG; Bae KB; Li Y; Cho YY; Curiel-Lewandrowski C; Einspahr J; Dickinson SE; Bode AM; Dong Z
Oncogene; 2018 Oct; 37(42):5633-5647. PubMed ID: 29904102
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.
Zykova TA; Zhu F; Lu C; Higgins L; Tatsumi Y; Abe Y; Bode AM; Dong Z
Clin Cancer Res; 2006 Dec; 12(23):6884-93. PubMed ID: 17145805
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032.
Eedara BB; Manivannan B; Alabsi W; Sun B; Curiel-Lewandrowski C; Zhang T; Bode AM; Mansour HM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958502
[TBL] [Abstract][Full Text] [Related]
17. T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.
Thanindratarn P; Dean DC; Nelson SD; Hornicek FJ; Duan Z
Cell Prolif; 2020 Oct; 53(10):e12901. PubMed ID: 32960500
[TBL] [Abstract][Full Text] [Related]
18. Scutellarin Suppresses RPMI7951 Melanoma Cell Proliferation by Targeting TOPK.
Mu X; Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S
Anticancer Agents Med Chem; 2021; 21(5):640-648. PubMed ID: 32781970
[TBL] [Abstract][Full Text] [Related]
19. ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK.
Gao G; Zhang T; Wang Q; Reddy K; Chen H; Yao K; Wang K; Roh E; Zykova T; Ma W; Ryu J; Curiel-Lewandrowski C; Alberts D; Dickinson SE; Bode AM; Xing Y; Dong Z
Mol Cancer Ther; 2017 Sep; 16(9):1843-1854. PubMed ID: 28655782
[TBL] [Abstract][Full Text] [Related]
20. Orobol, 3'-hydroxy-genistein, suppresses the development and regrowth of cutaneous SCC.
Roh E; Kim JE; Zhang T; Shin SH; Kim BG; Li J; Ma X; Lee KW; Dong Z
Biochem Pharmacol; 2023 Mar; 209():115415. PubMed ID: 36657604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
